Faster, More Frequent Proteinuria Reduction With Sparsentan in FSGS

(MedPage Today) — BOSTON — Patients with focal segmental glomerulosclerosis (FSGS) achieved some degree of proteinuria remission more often and more quickly on sparsentan (Filspari) than irbesartan (Avapro), secondary analyses of the phase…